Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Lung Cancer Survival Rate: Size Impacts
Lung Cancer Survival Rate: Size Impacts 4

Knowing the size of a lung tumor is key to figuring out the stage of lung cancer. It helps decide the best treatment. The bigger the tumor, the higher the chance of cancer.

A tumor is seen as large if it’s over 10 mm in size. Studies show tumors bigger than this have a higher chance of being cancer. This affects the lung cancer survival rate and how well you might do.

When dealing with lung cancer, knowing about tumor size is very important. It helps both patients and doctors make quick decisions. This can lead to better results and higher overall survival lung cancer rates.

Key Takeaways

  • Lung tumors over 10 mm are considered large and have a higher risk of being cancerous.
  • The size of a lung tumor significantly impacts the stage of cancer and treatment options.
  • Understanding lung cancer staging is key to knowing what to expect.
  • Tumor size is a big factor in choosing the right treatment.
  • Spotting cancer early and acting fast can greatly improve your chances.

Understanding Lung Tumors and Their Classification

Understanding Lung Tumors and Their Classification
Lung Cancer Survival Rate: Size Impacts 5

Lung tumors are abnormal growths in the lung tissue. They can be benign or malignant. Knowing their classification is key for effective treatment. Lung cancer is mainly divided into two types: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Definition of Lung Nodules vs. Masses

Lung nodules are small, rounded growths seen on imaging tests. Those over 30 mm are called lung masses. They are usually thought to be cancerous.

The difference between nodules and masses matters. It affects how doctors diagnose and treat them.

How Lung Tumors Are Measured

Lung tumors are measured with CT scans. Accurate measurement is vital. It helps determine the tumor’s size and its classification.

The size of a lung tumor tells doctors about its malignancy. It helps decide on the right treatment.

Benign vs. Malignant Lung Tumors

Benign lung tumors are non-cancerous and don’t spread. Malignant tumors are cancerous and can spread. Knowing if a tumor is benign or malignant is important.

It helps doctors choose the best treatment.

Size Thresholds for Lung Tumors

Size Thresholds for Lung Tumors
Lung Cancer Survival Rate: Size Impacts 6

Lung tumor size is key in diagnosing and staging lung cancer. The size helps determine the risk of cancer and guides treatment plans.

Small Nodules (Less Than 6mm)

Small nodules under 6mm are unlikely to be cancerous. Studies show they have less than a 1% chance of being malignant. So, they usually don’t need urgent treatment but might need follow-up scans.

Medium-Sized Nodules (6-10mm)

Nodules between 6-10mm have a moderate cancer risk. Their size increases the chance of cancer. They might need closer monitoring or more tests, like biopsies, based on other risk factors.

Large Nodules (Over 10mm)

Nodules over 10mm have a higher risk of being cancerous. Tumors this size have about a 15% chance of being malignant. They often need aggressive testing and treatment.

Masses (Over 30mm)

Masses over 30mm are large and have a high cancer risk. They are often in advanced lung cancer stages. They need thorough evaluation and treatment plans, considering lung cancer staging.

The table below shows the cancer risk for different lung nodule sizes:

Nodule Size (mm)

Cancer Risk (%)

Less than 6

Less than 1%

6-10

Moderate risk

Over 10

Roughly 15%

Over 30

High risk

Knowing the size thresholds for lung tumors is vital for accurate diagnosis and treatment. The tumor size affects the risk assessment and guides treatment decisions. This impacts lung cancer staging and patient outcomes.

The Correlation Between Tumor Size and Cancer Risk

It’s key to know how tumor size affects cancer risk. As tumors grow, so does the chance of cancer. This size is a big deal in figuring out cancer risk and how well a patient might do.

Risk Percentages Based on Size

Research shows that lung nodule risk changes with size. Small nodules under 6mm are less risky. But, nodules over 10mm are much more dangerous. Here’s a breakdown of the risks:

Nodule Size (mm)

Risk of Malignancy (%)

<6

0.5-1%

6-10

2-5%

>10

10-20%

>30 (Masses)

>50%

Why Size Matters in Cancer Diagnosis

The size of a lung tumor is very important. It affects lung cancer prognosis and treatment choices. Big tumors are more likely to be cancerous and harder to treat. Catching tumors early can greatly boost the stage1 lung cancer survival rate.

Other Factors That Influence Cancer Risk

Size is not the only thing that matters. Smoking history, family cancer history, and exposure to harmful substances also count. Knowing these things helps doctors figure out the best treatment to possibly increase the lung cancer cure rate.

Doctors look at tumor size and other factors to make a good plan. This detailed approach is key to better lung cancer treatment results.

Lung Cancer Staging and Tumor Size

Lung cancer staging uses the TNM system. It looks at tumor size, lymph node involvement, and distant metastasis. This helps doctors choose the right treatment.

TNM Classification System

The TNM system is key for lung cancer staging. It focuses on three main areas:

  • T (Tumor): Looks at the tumor’s size and spread.
  • N (Node): Checks if cancer has reached nearby lymph nodes.
  • M (Metastasis): Sees if cancer has spread to other parts of the body.

How Size Affects Staging

Tumor size is very important in lung cancer staging. Bigger tumors usually mean more advanced stages. For example, tumors over 5 cm are at least Stage 2B non-small cell lung cancer. Knowing how size impacts staging is key for treatment planning.

Stage 2B and Tumors Larger Than 5cm

Stage 2B lung cancer has tumors over 5 cm but hasn’t spread far. It might have reached nearby lymph nodes. Treatments for Stage 2B include surgery, radiation, and chemotherapy. The right treatment depends on the patient’s health and the tumor’s details.

Stage

Tumor Size

Lymph Node Involvement

Metastasis

Stage 1

Less than 3 cm

No

No

Stage 2B

Larger than 5 cm

Possible

No

Stage 3

Variable

Yes

No

Stage 4

Variable

Variable

Yes

Knowing the lung cancer stage is vital for treatment. The TNM system helps stage the disease, and tumor size is a big part of it.

Diagnostic Procedures for Different Sized Lung Tumors

Different sized lung tumors need special diagnostic methods for accurate diagnosis. This process is key to know if a tumor is cancerous and its stage.

Imaging Techniques

Imaging is a big part of diagnosing lung tumors. The main imaging tools are:

  • Computed Tomography (CT) scans, which give detailed lung images and help find tumor size and location.
  • Positron Emission Tomography (PET) scans, used with CT scans, to check tumor activity.
  • Chest X-rays, used first, but less detailed than CT scans.

Biopsy Methods

Biopsy methods are key for a lung tumor diagnosis. The biopsy method depends on tumor size, location, and patient health.

  • Needle biopsy, where a needle takes tumor tissue.
  • Bronchoscopy, a tube inserted through the mouth or nose to sample lung tissue.
  • Surgical biopsy, needed for hard-to-reach tumors or when more tissue is needed.

Follow-up Protocols Based on Size

Follow-up plans for lung tumors change based on tumor size and initial diagnosis. Small nodules might just need regular CT scans.

Tumor Size

Initial Assessment

Follow-up Protocol

Less than 6mm

Low risk, possibly benign

Annual CT scan

6-10mm

Moderate risk, potentially malignant

CT scan at 6, 12, and 24 months

Over 10mm

Higher risk, likely malignant

Biopsy or PET-CT scan, followed by treatment planning

Follow-up plans watch tumor growth and adjust treatment plans. Larger tumors or suspected malignancies get more aggressive diagnosis and treatment.

Treatment Approaches Based on Tumor Size

The way we treat lung cancer changes a lot based on the tumor size. For small tumors, we might just watch and wait. But for bigger ones, we might use surgery, radiation, or chemotherapy.

Watchful Waiting for Small Nodules

Small lung nodules, usually under 6mm, often get a watchful waiting approach. We keep an eye on them with imaging tests. This way, we catch any problems early without rushing into treatments.

Surgical Options for Larger Tumors

Bigger tumors might need surgery. We might take out the tumor and part of the lung, or even the whole lung. It depends on the tumor’s size, where it is, and the patient’s health. For big tumors, removing a lung is sometimes needed. While it’s a big surgery, many people can survive with one lung and make lifestyle changes.

Radiation and Chemotherapy Considerations

Radiation therapy and chemotherapy are used for tumors that can’t be removed or have spread. We pick these treatments based on the tumor’s size, stage, and the patient’s health. They can be used alone or with surgery to get the best results.

Targeted Therapies

Targeted therapies are a new way to fight cancer. They target specific molecules that help cancer grow. These therapies work well for some lung cancers and are often used with other treatments. They’ve helped increase the lung cancer cure rate, giving patients new hope.

It’s important for patients to know about the different treatments based on tumor size. This helps them make better choices about their care. By looking at the tumor size and other factors, doctors can suggest the best treatment. This can lead to better treatment results and a better quality of life for patients.

Lung Cancer Survival Rate Based on Tumor Size

Lung cancer survival rates are closely linked to the size of the tumor at diagnosis. Knowing this is key for both patients and healthcare providers. It helps in making treatment decisions and understanding the prognosis.

Early-Stage Small Tumors and Survival

Early-stage lung cancer, with small tumors, has a better survival rate. Tumors less than 3 cm in size are often diagnosed early. This leads to a more favorable prognosis.

Patients with stage 1 lung cancer, where the tumor is small and localized, often have a higher five-year survival rate. This shows how important early detection is for better survival outcomes.

Advanced-Stage Large Tumors and Prognosis

Larger tumors or those diagnosed at an advanced stage have a poorer prognosis. The survival rate drops as the tumor grows, and when cancer spreads to lymph nodes or distant organs. Advanced-stage lung cancer needs aggressive and complex treatments.

Five-Year Survival Statistics

Five-year survival statistics show how tumor size affects lung cancer outcomes. For stage 1 lung cancer, the five-year survival rate is much higher than for more advanced stages. Studies show that early detection and treatment greatly improve survival rates.

Factors That Improve Survival Outcomes

Several factors can boost lung cancer survival rates. These include early detection, proper treatment planning, and new therapies. A team approach to treatment, using surgery, radiation, and targeted therapies, is key.

Understanding the link between tumor size and survival rate helps patients and healthcare providers make better decisions. This leads to improved outcomes for lung cancer patients.

Differences Between Non-Small Cell and Small Cell Lung Cancer

NSCLC and SCLC are the two main types of lung cancer. They differ in how they grow and how they are treated. NSCLC makes up about 85% of cases, while SCLC makes up about 15%. Knowing these differences is key for planning treatment.

Size Considerations in NSCLC vs. SCLC

Tumor size matters in both NSCLC and SCLC, but in different ways. NSCLC uses the TNM system, where size is a big factor in stage N2 NSCLC. SCLC, though, looks at size among other things, like how far it has spread.

Growth Patterns and Spread

NSCLC grows and spreads slower than SCLC. SCLC grows fast and spreads early, needing stronger treatments.

Impact on Treatment Decisions

The choice between NSCLC and SCLC affects treatment plans. NSCLC might get surgery, targeted therapy, or radiation, based on its stage. SCLC, being aggressive, usually gets chemotherapy and radiation.

Living with One Lung: Post-Surgical Considerations

Many patients live with one lung after lung cancer surgery. Thanks to medical progress, more people survive this surgery. It’s important to know what to expect after surgery.

When Tumor Size Necessitates Pneumonectomy

Big lung tumors might need a whole lung removed, called pneumonectomy. This is when other surgeries won’t work. Doctors decide on pneumonectomy after checking with tests and scans.

Tumor size is a big factor in choosing pneumonectomy. Large or central tumors often need this surgery. Before surgery, doctors check if patients can recover well.

Quality of Life After Lung Removal

Patients often wonder about life after losing a lung. While it’s a big surgery, many live active lives. Good care, lifestyle changes, and medical follow-up are key.

“The ability to survive and thrive after a pneumonectomy is a testament to the advancements in surgical techniques and post-operative care.” Thoracic Surgeon

Adaptation and Rehabilitation

Recovering from lung surgery needs adaptation and rehab. Pulmonary rehab helps patients breathe better and regain strength. It includes exercises, lung health education, and nutrition advice.

Rehabilitation Component

Description

Benefits

Exercise Training

Guided physical exercises to improve cardiovascular health and strength

Enhanced endurance, reduced fatigue

Lung Health Education

Information on managing lung health, including breathing techniques

Improved lung function, better symptom management

Nutritional Counseling

Dietary advice to support overall health and recovery

Optimal nutrition, healthy weight management

Long-term Health Management

After pneumonectomy, managing health long-term is key. Regular check-ups, staying healthy, and getting vaccines are important. This helps prevent infections.

With the right care, many live well with one lung. It’s not just about the surgery. It’s about a whole approach to health after surgery.

Conclusion: The Importance of Early Detection

Early detection is key to better lung cancer survival rates. We’ve learned that tumor size greatly affects diagnosis and treatment. When caught early, treatments work better, leading to longer lives.

Studies show early detection boosts lung cancer prognosis. Finding tumors early means doctors can use less invasive treatments. This improves life quality and survival chances. Regular check-ups are vital, mainly for those at high risk.

Knowing how tumor size relates to cancer risk helps patients. It also informs them about available treatments. We aim to provide top-notch care to all, ensuring everyone gets the best lung cancer treatment.

FAQ

What is considered a large lung tumor?

A lung tumor is considered large if it’s over 30mm in diameter. Tumors this size are often called masses. They have a higher chance of being cancerous.

How are lung tumors measured?

Lung tumors are measured with imaging like CT scans or X-rays. The size is based on the tumor’s largest diameter.

What is the difference between a lung nodule and a lung mass?

A lung nodule is under 30mm, while a lung mass is over 30mm. This difference is important because larger masses are more likely to be cancerous.

What is the cancer risk associated with small lung nodules?

Small lung nodules, under 6mm, rarely have cancer, less than 1%. But, the risk goes up with size. Nodules between 6-10mm have a risk of 1-10%.

How does tumor size affect lung cancer staging?

Tumor size is key in lung cancer staging. Larger tumors mean more advanced stages. This affects treatment choices and outlook.

What are the treatment options for lung tumors based on size?

Treatment depends on tumor size. Small nodules might just be watched. But, larger tumors often need surgery, radiation, or chemotherapy.

Can you survive with one lung?

Yes, surviving with one lung is possible. The lung can work well with just one. But, managing long-term health and quality of life is important.

What is the difference between NSCLC and SCLC?

NSCLC and SCLC are two lung cancer types. NSCLC is more common and grows slower. SCLC is aggressive and linked to smoking.

How does the size of a lung tumor impact overall survival?

Lung tumor size greatly affects survival. Small, early-stage tumors have a better outlook than large, advanced tumors. Survival rates vary with size and stage.

What is the lung cancer survival rate for stage 1 lung cancer?

Stage 1 lung cancer survival rates are higher. For NSCLC, the five-year survival rate can be 50-90% or more. It depends on the tumor and patient’s health.

How does tumor size influence the choice of treatment for NSCLC?

Tumor size is critical in treating NSCLC. Small tumors might get surgery or localized treatments. But, larger tumors often need chemotherapy and radiation.

What are the post-surgical considerations for patients after a pneumonectomy?

After a pneumonectomy, patients must adapt to one lung. They need rehabilitation, manage complications, and ensure long-term health for the best quality of life.

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from


References

https://my.clevelandclinic.org/health/diseases/4375-lung-cancer

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91